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Monocyte functionAgeing is accompanied by reduced functioning of the immune system, termed immunesenescence which is
associated with increased risk of infection and mortality. However the immune system does not operate in iso-
lation and can bemodiﬁedbymany environmental factors, including stress. In this studywedeterminedwhether
physical stress (hip fracture) and psychological distress (depressive symptoms) had additive effects upon
the aged immune system, speciﬁcally on monocyte numbers and function. We assessed immune function in
101 hip fracture patients (81 female) 6 weeks and 6 months after injury and 43 healthy age matched controls
(28 females). Thirty-eight of the hip fracture group were found to be depressed at the 6 week sampling.
No differences in peripheral monocyte count, distribution ofmonocyte subsets or TNFα secretion were observed
between hip fracture patients and healthy controls. However we observed signiﬁcantly reduced superoxide
production in response to Escherichia coli in the monocytes of hip fracture patients who developed depressive
symptoms compared with non-depressed hip fracture patients (p = 0.002) or healthy controls (p = 0.008)
6 weeks after the fracture which remained decreased 6 months following injury. In previous studies we have
shown an effect of depression on neutrophil superoxide generation in hip fracture patients, suggesting a particular
susceptibility of this aspect of immune cell function to psychological stress.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
Stress is a frequent precipitant of major depression (Leonard and
Myint, 2009) and chronic age-related diseases such as cardiovascular
disease, rheumatoid arthritis, cancer, and lung disease have long been
known to have a negative impact on the psychological wellbeing of
older people, resulting in development of depressive symptomatology
(Bisschop et al., 2004). Hip fracture is a devastating condition and a
major health issue in old age (Abrahamsen et al., 2009) and a high
prevalence of depression ranging from 9% to 47% has been reported
post-hip fracture in older adults (Holmes andHouse, 2000). Importantly,
depression in hip fracture patients has been associated with increased
risk of infections and poor survival (Nightingale et al., 2001) and an
impaired ability to regain pre-fracture levels of physical functioning
(Mossey et al., 1990). A 1–3% increase in the frequency of hip fractures
per year has been reported worldwide (Cummings and Melton, 2002).sculoskeletal Ageing Research,
am, Birmingham B15 2TT, UK.
. This is an open access article underThus, understanding the health implications of this common injury
for older people and the additive effect of development of depressive
symptoms is now imperative.
Ageing results in altered immunological dynamics and reduced
immunity (Dorshkind et al., 2009; Panda et al., 2009), termed
immunesenescence, contributing towards an increased risk of morbid-
ity andmortality in older adultsmost notably an increase in susceptibil-
ity to infections (Bonomo, 2002; Gavazzi and Krause, 2002). Monocytes
and their tissue equivalent macrophages, play a key role in innate
immunity acting as early sensors of infections by detecting pathogens
via their Toll-like receptors (TLRs) for pathogen associated molecular
patterns (PAMPs) and releasing pro-inﬂammatory cytokines to recruit
additional leukocytes. The differential expression of CD14 and CD16
have been used to deﬁne three peripheral subsets of monocytes:
classical (CD14+ CD16−) represent approximately 90% of monocytes
in a healthy individual; intermediate (CD14+ CD16+) and non-
classical monocytes (CD14+ CD16++) make up the remaining fraction
(Passlick et al., 1989). There is also considerable complexity in the
functionality ofmonocyte lineages, with these cells having the potential
for differentiation into not only macrophages but also speciﬁc classes
of inﬂammatory dendritic cells (Auffray et al., 2009). In this waythe CC BY license (http://creativecommons.org/licenses/by/3.0/).
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and adaptive immune system in their role as antigen presenting cells.
Monocyte numbers do not change signiﬁcantly with ageing
(Takahashi et al., 1985; Gomez et al., 2008) but there are changes
to the distribution of monocyte subsets with age: non-classical
CD14+CD16+ monocytes increase signiﬁcantly with age resulting in a
shift from classical to non-classical monocytes (Seidler et al., 2010;
Nyugen et al., 2010). Early studies reported impaired phagocytic func-
tion (Hearps et al., 2012) and a decline in reactive oxygen and nitrogen
species release in monocytes from old donors (McLachlan et al., 1995;
Alvarez and Santa Maria, 1996). Monocytes are also signiﬁcant pro-
ducers of pro-inﬂammatory cytokines and a study of monocytes from
154 young and old individuals found an age-associated reduction in
TNF-α and IL-6 secretion after stimulation through the TLR1/2 heterodi-
mer and a decrease in TLR7-mediated IL-6 production though TNF-α
and IL-6 production in response to ligation of TLR2/6, TLR4, and TLR5
was unaffected by ageing (van Duin et al., 2007a). In addition, TLR-
induced upregulation of the costimulatory molecule CD80 on mono-
cytes after stimulation through TLR1/2, TLR2/6, TLR4, TLR5, and TLR7/
8 all showed a substantial age-associated decline (van Duin et al.,
2007a).
It is well accepted that stress is a potent suppressor of immune
function (Segerstrom and Miller, 2004; Zorrilla et al., 2001). However,
data regarding the effect of stress on monocytes are limited; there are
only a few studies done in depressed patients (Schlatter et al., 2004;
Lisi et al., 2013) and there is one study exploring the effect of surgical
stress which has reported dysregulated monocyte functioning (Ono
et al., 2001). Importantly, normal ageing is associated with increased
incidence of psychological distress (Bauer et al., 2009), which may
therefore further compromise or be a key component of the normal
age-related decline in immunity seen in older adults. The physiological
response to stress requires activation of the hypothalamus–pituitary–
adrenal (HPA) axis involving increased secretion of glucocorticoids
(Charmandari et al., 2005), which have potent immunosuppressive
properties including altered cytokine production (Tsianakas et al.,
2012) and suppression of superoxide generation (Tsianakas et al.,
2012; Butcher et al., 2005). Dehydroepiandrosterone (DHEA) is also
secreted by the adrenals and is present in the circulation in its sulphated
form DHEAS at micromolar concentrations. In contrast to glucocorti-
coids DHEA and DHEAS have been reported to have immune-
enhancing properties, including enhanced monocyte function
(McLachlan et al., 1996) and increased human neutrophil function
(Radford et al., 2010). Normal ageing is accompanied by an altered
HPA axis due to the sharp decline in the production of DHEA/S, termed
adrenopause (Orentreich et al., 1984; Hazeldine et al., 2010) and an ex-
aggerated HPA axis after stress (Wilkinson et al., 1997; Pedersen et al.,
2001). The result is increased cortisol levels as compared to young indi-
viduals in stressful conditions which may compromise further the age-
associated immune decline.
We set out to test the hypothesis that ageing, physical stress
and psychological stress are key interacting factors that could have
an additive detrimental effect on immune functioning in older adults.
We examined the combined effect of the physical stress of hip fracture
and psychological stress, speciﬁcally depression, on monocyte subset
distribution, bactericidal properties, cytokine production and antigen
presentation and co-stimulatory capacity in older adults.
2. Materials and methods
2.1. Participants
101 older hip fracture patients were recruited from ﬁve hospitals in
Birmingham, UK between 2010 and 2012. Inclusion criteria were that
participants had to be aged 60 years and over with a hip fracture
sustained 4–6 weeks previously but with no chronic immune-related
disorders e.g., cancer, diabetes, or taking any regular medicationsthat might modify immunity, e.g., immunosuppressants. Additionally
patients must not have had any diagnosis of depression by a physician
prior to age 50 years or be taking or have previously taken anti-
depressant medication, in order to pick up patients with depressive
symptoms emerging post-hip fracture rather than those with a prior
history of and thus propensity to depression. 43 healthy older adults
were also recruited from the community as controls. These controls
also had to meet the inclusion criteria above but not have a current
hip fracture. The study was approved by South Birmingham Local
Research Ethics Committee and all participants provided written
informed consent (study ref: 09/H1203/80).
2.2. Study design and procedure
The study was a prospective case–control design with three groups
of older adults: hip fracture patients with or without depressive
symptoms and healthy older adults. Consent was gainedwhilst patients
were still in hospital. All patients completed questionnaires, structured
interviews and provided a blood sample 4–6 weeks and six months
after hip fracture. Control participants completed a depression and
anxiety symptoms scale and basic demographic information when
attending the university for a single blood sampling. Blood samples
were taken between 09.00 and 11.00 to minimise any effect of diurnal
variations in steroid levels. None of the participants had an acute
infection at the time of blood sampling. Interviews were performed
either in the hospital or in the patient's home for hip fracture patients
and at the university for control participants.
The psychological status of the participant was assessed bymeans of
standardised psychometric questionnaires. Depression was evaluated
by a Geriatric Depression Scale (Yesavage et al., 1982). Depression
was deﬁned as a GDS score greater than or equal to 6 (Sheikh and
Yesavage, 1986). The Hospital Anxiety and Depression Scale was also
used to measure depression and anxiety (Zigmond and Snaith, 1983).
The scale contains 14 items, scored from 0 (not present) to 3 (consider-
able), with seven assessing aspects of depression and seven assessing
anxiety.
2.3. Monocyte function assays
Monocyte phagocytic ability was measured in whole blood using a
commercially available kit (Phagotest kit, Orpegen Pharma, Germany)
and the assays were performed according to manufacturer's instruc-
tions. Brieﬂy, FITC-labelled opsonised Escherichia coli were added to
whole blood and incubated at 37 °C for 10 min and the control tube
was kept on ice for 10 min. Following incubation, a quenching solution
was added to each tube to stop the reaction and red blood cells were
lysed. Following the lysis step the cell suspension was resuspended in
DNA staining solution and ﬂuorescence was analysed immediately
using a CyanTM ADP ﬂow cytometer (Dako Ltd., Cambridge, UK). Data
were analysed using Summit V 4.3. The phagocytic index was used
as a measurement of the phagocytic capabilities of monocytes and
was calculated as the percentage of cells that had ingested bacteria,
multiplied by the mean ﬂuorescence intensity (MFI), divided by 100.
Monocyte superoxide burst was measured in whole blood using
a commercially available kit (Phagoburst kit, Orpegen Pharma). The
assays were performed according to manufacturer's instructions.
Whole blood was treated with 100 nM fMLP (Sigma-Aldrich, Dorset,
UK), 20 nM PMA (Sigma-Aldrich) or opsonised E. coli (Orpegen
Pharma) at 37 °C for 10 min. Following incubation, ﬂuorogenic sub-
strate dihydrorhodamine (DHR) 123 (Dako) was added to the blood
sample at 37 °C for 10 min. Post-incubation, cells were lysed after
which DNA staining solution was added. Oxidation of substrate
DHR123 was analysed by ﬂow Cytometry using a CyanTM ADP ﬂow
cytometer. The oxidative burst production is indicated by the MFI of
the monocyte population.
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of monocytes
PBMCs were isolated from peripheral blood by density centrifuga-
tion using Ficoll-PaqueTM PLUS (GE Healthcare, Uppsala, Sweden).
The blood was layered on top of 6 ml of Ficoll-PaqueTM PLUS in a
25 ml Universal tube and the tube was centrifuged at 650 ×g for
30 min with no break. Post-centrifugation, the mononuclear cell layer
containing PBMC was removed and added to a new universal tube
and the cells were washed twice with PBS and were counted on a
haemocytometer. Isolated PBMCs were frozen down by re-suspending
cells in freezing medium consisting of 10% DMSO (Sigma-Aldrich, UK)
in heat inactived foetal calf serum (Biosera, UK) and transferring them
in small aliquots into cryovials. The cryovials were transferred into a
freezing container (Mr. Frosty, Sigma-Aldrich, UK) containing
isopropanol (VWR International, UK). Cells were then stored at
−80 °C.
Frozen cells were thawed in a water bath at 37 °C and were washed
in 10 ml of RPMI 1640 (Sigma-Aldrich, UK) to remove DMSO.
Post-washing, PBMCs were resuspended in PBS at a concentration of
1 × 106/ml. For phenotypic characterisation of monocytes, isolated
PBMCs were stained with a combination of ﬂuorochrome conjugated
antibodies including; CD14-Pac blue (Bio Legend, UK; clone M5E2),
CD16-FITC (eBiosciences, UK; clone CB16), HLADR-PE (Serotec, clone:
MCA1879), CD80-APC (Bio legend, UK; clone 2D10) and CD86-APC
(Bio legend, UK; clone IT2.2). Appropriate isotype controls were used
for setting gates. Following incubation, cells were washed and resus-
pended in PBS for ﬂow cytometric analysis using a CyanTM ADP ﬂow
cytometer (Dako).2.5. Monocyte stimulation — lipopolysaccharide (LPS)
Frozen PBMCswere resuspended in RPMImedium containing 2mM
L-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin (Sigma-
Aldrich) supplemented with 10% heat-inactivated foetal calf serum
(Sera Laboratories International, Sussex, UK) at a concentration of
1 × 106/ml for functional analysis. Time course experiments were per-
formed to examine the TNFα production by monocytes at 1 h, 2 h,
4 h, 8 h, 24 h and 48 h stimulations (data not shown). From these
data, monocytes were stimulated with LPS isolated from E. coli serotype
0111:B4 (1 μg/ml; Sigma-Aldrich) for 4 h in the presence of Brefeldin A
(10 μg/ml; Sigma-Aldrich) to inhibit cytokine secretion. Cells were then
washed and stained for CD14 to identify the monocytes and cells were
then ﬁxed (Reagent A; Fix and Perm kit, Invitrogen Ltd., Paisley,
Scotland) and permeabilised (Reagent B; Fix and Perm kit, Invitrogen).
Permeabilised cells were stained with anti-human TNFα-PE antibody
(Bio legend, clone: MAb11) for intracellular staining. Appropriate
isotype controls were used for gate setting for measuring cytokine
expression. Cellswere analysed using a CyanTMADP (Dako). Data analysis
was carried out using Summit v4.3x.
Additionally, monocytes were also stimulated with LPS isolated
from E. coli serotype 0111:B4 (1 μg/ml; Sigma-Aldrich) for 4 h in the
absence of Brefeldin A. These culture supernatants were snap frozen
in liquid nitrogen and stored at −80 °C for subsequent analysis of
TNFα secretion by monocytes. TNFα levels in supernatants were mea-
sured by enzyme-linked immunosorbent assays (ELISA) using a com-
mercial kit (Abcam, Cambridge, UK), according to manufacturer's
instructions.2.6. Serum cortisol and DHEAS assays
Serum cortisol and DHEAS levels were measured by ELISA using a
commercial kit (IBL International, Hamburg, Germany) according to
manufacturer's instructions.2.7. Statistical analysis
Univariate ANOVA with least signiﬁcant difference post-hoc tests
were used to assess differences between the three groups (hip fracture
with depressive symptoms, hip fracture without depressive symptoms,
and healthy controls). Where demographic variables differed signiﬁ-
cantly between the groups, analyses were rerun adjusting for these
variables using ANCOVA. Pearson's correlations were used to examine
associations between depression score and monocyte function and
hormone levels. Repeated measures ANOVA models were used to
examine changes in monocyte functioning between the 6 week and
6 month sampling time points.
3. Results
3.1. Participant demographics
The full demographic statistics for the study participants have been
reported previously (Phillips et al., 2013). There were no differences
between the patients who developed depression and those who did
not for major demographic features, though the healthy control group
were younger (74.9 ± 5.64 years, p b 0.001) than the hip fracture
only (83.8 ± 7.48 years) and hip fracture with depression groups
(84.0 ± 8.62 years) and also had a higher BMI (27.5 ± 5.02,
p b 0.001) than either of the patient groups (23.5 ± 3.81 hip fracture
alone; 22.7 ± 4.03 hip fracture with depression). All statistical compar-
isons were therefore adjusted for these two measures. Patients were
classiﬁed into two groups on the basis of their GDS scores: hip fracture
patients with a GDS score of 5 or less were classiﬁed as non-depressed
(HF; hip fracture only), those with a score of greater than 5 were
categorised as depressed (HF + D; Hip fracture patients with depres-
sion). None of the recruited patients had a prior history of depression
and in this study we observed that 38 (37%) of the hip fracture patients
had developed depression after their injury. This is in linewith previous
studies that have reported a high prevalence of depression in hip
fracture patients (Nightingale et al., 2001).
3.2. Distribution of monocyte subsets
The contribution of the three subsets of monocytes: classical
(CD14+ CD16−), intermediate (CD14+ CD16+) and non-classical
(CD14+ CD16++), to themonocyte pool was determined in the periph-
eral blood of hip fracture patients with and without depression with
healthy older adults. There was no signiﬁcant difference in total mono-
cyte count between the three groups, F (2, 65) = .37, p = .69, η2 = .01
[Fig. 1A]. We also found no difference in the percentage of classical
(CD14+ CD16−) monocytes between the two groups of hip fracture pa-
tients and healthy controls F (2, 67) = .23, p = .79, η2 = .007 [Fig. 1B],
or in the percentage of ‘intermediate’ monocytes F (2, 67) = .30, p =
.73, η2 = .009 or ‘non-classical’ monocytes F (2, 67) = .43, p = .64,
η2 = .01 between the three groups [Fig. 1C and D].
3.3. Monocyte function in hip fracture patients
On comparing monocyte phagocytic ability between the three
groups althoughwe observed a trend towards an increase in phagocytic
ability of monocytes in the hip fracture patients, though this failed to
reach statistical signiﬁcance F (2, 81) = 2.15, p = .12, η2 = .05
(Fig. 2A). Phagocytosis of pathogens by monocytes is followed by
intracellular killing via superoxide production. Upon examining
the ability of monocytes to generate superoxide in response to
opsonised E. coli, we observed signiﬁcant differences between the
three groups F (2, 82) = 7.41, p = .001, η2 = .15, but the signiﬁcant
impairment in superoxide generation was restricted to the hip fracture
patients who developed depression, when compared either to healthy
controls (p = .008) or to hip fracture patients without depression
Fig. 1.Monocyte counts and monocyte subsets in hip fracture patients six weeks post-surgery. (A) The absolute numbers of monocytes in peripheral blood of hip fracture patients and
controls; the percentage of (B) CD14+ CD16−, (C) CD14+ CD16+ and (D) CD14+ CD16++ monocytes in peripheral blood of hip fracture patients and controls. Data are mean ± SEM.
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adjustment for age, sex and BMI, the superoxide production in response
to E. coli F (2, 70) = 6.72, p = .002, η2 = .16 remained signiﬁcant for
the hip fracture plus depression group (data not shown).
We also evaluated the long termeffect of hip fracture and depressive
symptoms on immune functioning of older adults. On examining
monocyte superoxide production in hip fracture patients six months
after surgery, the main effect of time on both groups of hip fracture
patients was not signiﬁcant F (1, 38) = 2.31, p = .13, η2 = .05, and
no signiﬁcant improvement in superoxide production by monocytes
was seen at 6 months compared with 6 weeks in the hip fracture
group with depression (Fig. 2C).
3.4. Cytokine secretion by monocytes
In addition to anti-microbial activity monocytes are capable
of participating in the inﬂammatory response by producing pro-
inﬂammatory cytokines such as TNFα and IL1-β (Orentreich et al.,
1984). On assessing cytokine production capacity of monocytes by
intracellular cytokine detection using immunostaining and ﬂow cytom-
etry, we failed to ﬁnd any signiﬁcant differences in the percentage of
monocytes producing TNFα between the three groups in untreated
cells F (2, 33) = 1.24, p = .30, η2 = .07 (data not shown) or after 4 h
LPS stimulation F (2, 32)= .08, p = .92, η2 = .05 (Fig. 3A). To examine
TNFα secretion by monocytes we performed an ELISA on cell culture
supernatants. There was no difference in TNFα secretion between
the three groups in the untreated condition F (2, 26) = .04, p = .95,
η2 = .003 (data not shown) or after 4 h LPS stimulation F (2, 22) =
.20, p = .75, η2 = .02 (Fig. 3B).
3.5. Expression of co-stimulatory molecules and MHC by monocytes
Next, we evaluated the expression of co-stimulatory molecules
CD80 and CD86 on monocytes of hip fracture patients and healthy con-
trols. The percentage of monocytes expressing CD80 F (2, 41) = 1.67,p = .20, η2 = .07 and its expression levels F (2, 40) = 1.86, p = .16,
η2 = .08 did not differ between the three groups [Fig. 4A and B
respectively] and neither did the percentage of monocytes expressing
CD86, F (2, 49) = 0.13, p = .87, η2 = .005 or CD86 expression levels
F (2, 49)= 1.41, p= .25, η2= .05 [Fig. 4C and D respectively]. Addition-
ally, we also examined the expression of co-stimulatory molecules CD80
and CD86 on the threemonocyte subsets and failed to ﬁnd any signiﬁcant
differences between the hip fracture groups and healthy controls
(data not shown).
A reduction in human leukocyte antigen class II (HLA-DR) expres-
sion inmonocytes has been reported during stressful situations, includ-
ing after surgery (Handy et al., 2010), during systemic inﬂammation
(Kim et al., 2010), or sepsis (Fingerle et al., 1993) and has been associ-
ated with poor outcome. However, the effect of physical distress or
depression on HLADR expression in monocytes has not been reported.
In this study, we did not observe any differences in the percentage of
monocytes expressing HLADR, F (2, 50) = 1.58, p = .21, η2 = .06
[Fig. 4E] or in the surface expression of this molecule, F (2, 50) =
0.62, p = .53, η2 = .02 [Fig. 4F] between the three groups. It is possible
that the HLADR expression on monocytes was reduced immediately
after hip fracture surgery, but we have only examined HLADR expres-
sion on monocytes six weeks after injury and surgery.
3.5.1. Cortisol:DHEAS ratio and monocyte superoxide production
To try and determine if depression might be driving the reduced
monocyte superoxide response we correlated GDS score with superox-
ide generation. The data show an association betweenmonocyte super-
oxide production and depressive symptoms in hip fracture patients,
GDS score predicted monocyte superoxide production in hip fracture
patients β = − .32, p = .01, ΔR2 = .10 [Fig. 5A]. We have recently
reported an increase in the cortisol and the cortisol:DHEAS ratio in the
patients with hip fracture and depression compared to hip fracture
alone or to healthy controls (Duggal et al., 2013). However, we did
not ﬁnd a signiﬁcant association between the serum cortisol:DHEAS
ratio, β=− .12, p= .37,ΔR2= .01 (data not shown), or serum cortisol,
**
A B
C
Fig. 2.Monocyte phagocytosis and superoxide production on stimulationwith E. coli in hip fracture patients. (A)Monocyte phagocytic index for hip fracture patientswith depression (n=26),
hip fracture patients without depression (n=31) and healthy controls (n= 18). The solid bar represents themean value. (B)Monocyte superoxide production (MFI) for hip fracture patients
with depression (n = 27), hip fracture patients without depression (n = 40) and healthy controls (n = 22). The solid bar represents the mean value. (C) Mean monocyte superoxide
generation for hip fracture patients with depression (n = 21) at 6 weeks and 6 months post-injury. Data are mean ± SEM and * indicates p b 0.05 and ** indicates p b 0.005.
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the hip fracture patients [Fig. 5B].
4. Discussion
The high incidence of depression after hip fracture, seen in approxi-
mately one-third of our hip fracture patients at six weeks post-surgery,
is consistent with previous studies of depression in hip fracture patients
(Holmes and House, 2000; Lenze et al., 2007). In this study, for the ﬁrst
time we report that the psychological stress of depression rather thanFig. 3.Monocyte cytokine production capacity upon LPS stimulation in hip fracture patients si
patientswith depression (n=12), hip fracture patientswithout depression (n=12) andhealthy
upon LPS stimulation in hip fracture patients with depression (n = 12), hip fracture patients witthe physical stress of a hip fracture had a negative effect on monocyte
function. Interestingly, the effect of depression on monocyte function
was not universal and was restricted to impairment in bactericidal
properties, speciﬁcally superoxide generation, with no effect on phago-
cytic ability, TNFα secretion or expression of co-stimulatory and antigen
presenting molecules. Further, this suppressed monocyte functioning
observed in hip fracture patients with depression persisted up to six
months after injury, suggesting that depression in hip fracture
patients results in a long term suppression of monocyte bactericidal
properties.x weeks post-surgery. (A) The percentage of monocytes producing TNFα for hip fracture
controls (n=12). The solid bar represents themean value. (B) TNFα secretion bymonocytes
hout depression (n = 12) and healthy controls (n = 12). Data are mean ± SEM.
Fig. 4.Monocyte expression of co-stimulatory molecules and HLA-DR in hip fracture patients six weeks post-surgery. (A) The percentage of CD80+ monocytes in hip fracture patients
with depression (n=15), hip fracture patients without depression (n=16) and healthy controls (n=18). (B) CD80 expression bymonocytes fromhip fracture patientswith depression
(n= 15), hip fracture patients without depression (n= 16) and healthy controls (n = 18). (C) The percentage of CD86+ monocytes in hip fracture patients with depression (n= 15),
hip fracture patients without depression (n = 18) and healthy controls (n = 18). (D) CD86 expression by monocytes from hip fracture patients with depression (n = 15), hip fracture
patients without depression (n = 18) and healthy controls (n = 18). (E) The percentage of HLADR+ monocytes in hip fracture patients with depression (n= 18), hip fracture patients
without depression (n = 18) and healthy controls (n = 18). (F) HLADR expression by monocytes from hip fracture patients with depression (n = 18), hip fracture patients without
depression (n = 18) and healthy controls (n = 18).
A
p = .017
B
Fig. 5. Relationship of cortisol and cortisol:DHEAS ratiowithmonocyte superoxide production in hip fracture patientswith depression. Linear regression plots for the relationship between
(A) GDS score and superoxide generation by monocytes; (B) serum cortisol and superoxide generation by monocytes in hip fracture patients (n = 62).
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33N.A. Duggal et al. / Experimental Gerontology 54 (2014) 27–34On examining the effect of physical trauma (hip fracture) and
psychological stress (depressive symptoms) on peripheral monocyte
counts we did not observe any signiﬁcant differences in peripheral
monocyte count between our three groups, which is in line with previ-
ous ﬁndings of unaltered circulating monocyte counts in depressed in-
dividuals (Schlatter et al., 2004). Further, the presence of depressive
symptoms in hip fracture patients does not have an effect on the
peripheral frequency of CD14+veCD16−ve or CD14+veCD16+ve
monocytes, which has also been previously reported in depressed
patients (Schlatter et al., 2004).
Previous studies evaluating the impact of ageing on innate immu-
nity have reported impairments in monocyte reactive oxygen spe-
cies generation in older adults (Panda et al., 2009; Alvarez and
Santa Maria, 1996). The question addressed here was whether stress
would further worsen the age associated impairments in monocyte
bactericidal properties. Our previous work has reported reduced su-
peroxide generation by neutrophils in older hip fracture patients
(Butcher et al., 2005), and our recent analysis of neutrophil function
in this patient cohort showed that hip fracture patients with depression
had reduced superoxide generation compared to hip fracture patients
without depression and healthy controls (Duggal et al., 2013). Previous
studies have also associated psychological stressors, such as bereave-
ment in older adults with impaired neutrophil superoxide generation
(Khanfer et al., 2011), but to our knowledge our study is the ﬁrst to ex-
amine the effect of stress on superoxide production by monocytes in
older adults. However, one study reported an increase in superoxide
generation by monocytes in depressed individuals, but in this study the
monocyte parameters were measured in only ten individuals with
major depression and these were all young subjects (Schlatter et al.,
2004). Taken together, our data suggest that superoxide generation by
innate immune cells is most susceptible to psychological stress. This im-
pairment in neutrophil and monocyte defences may be of clinical signif-
icance and might underlie the increased susceptibility to infections
previously reported in hip fracture patients (Butcher et al., 2005), though
this studywas not adequately powered to detect a difference in infection
rates.
Neuro-hormonal dysregulation is a prominent ﬁnding in depression
(Gold and Chrousos, 2002). Previous studies have reported an associa-
tion between psychological wellbeing and HPA axis activity, speciﬁcally
an increased cortisol level has been reported in depressed patients
(Gold et al., 1988; Burke et al., 2005).We have also previously reported
an increased serum cortisol:DHEAS ratio in hip fracture patients
(Butcher et al., 2005) and the same was found here for both cortisol
and the cortisol:DHEAS ratio, but only for the patients who developed
depression. In vitro studies have reported a suppressive effect of gluco-
corticoids on monocyte bactericidal properties, especially superoxide
generation (Tsianakas et al., 2012; Ehrchen et al., 2007). The activation
of the NADPH oxidase complex involving association of cytosolic
components p47phox, p67phox, and p40phox with membrane bound
gp91phox and p22phox, catalyses electron transfer from NADPH to
oxygen resulting in superoxide generation (Babior et al., 2002). A
study examining the effect of dexamethasone on the humanmonocytic
THP-1 cell line reported a down regulation of NADPH oxidase system
due to inhibition of expression of p47phox genes (Condino-Neto et al.,
1998). However we found no association between either cortisol or the
cortisol:DHEAS and superoxide generation, but we did ﬁnd an associa-
tion for depression (GDS) and the cortisol:DHEAS ratio.
An age-associated impairment in cytokine production bymonocytes
(IL6, TNFα) has been reported on stimulationwith TLR1/2 agonists (van
Duin et al., 2007b; Delpedro et al., 1998). However, the additional effect
of physical stress of hip fracture and psychological distress of depres-
sion does not appear to further exaggerate the age-associated decline
in cytokine production by monocytes. Our ﬁndings are consistent with
other studies that have reported intact monocyte cytokine production
upon stimulation with bacterial components in depressed younger
patients (Landmann et al., 1997), suggesting that the ability ofmonocytes to respond to mitogen stimuli remains unaffected by expo-
sure to chronic stress in both young and older adults.
Monocytes express a spectrum of cell surface molecules including
co-stimulatory molecules CD80 and CD86 that play an essential role
in for mediating T cell response to infectious agents (van Duin et al.,
2007a; Fleischer et al., 1996). Ageing is accompanied by a diminished
monocyte co-stimulatory activity, due to reduced CD80 expression
(Strohacker et al., 2012). However, the additional physical stress
of hip fracture and psychological distress of depression did not affect
expression of B7 molecules (CD80 and CD86) on monocytes in older
adults. In addition to providing co-stimulatory signals, monocytes are
also capable of antigen presentation to T cells via MHC-II molecule
human leukocyte antigen DR (HLA-DR), which has been reported to
remain unaltered with major depression (Landmann et al., 1997).
Our ﬁndings are consistent with this study as we found no signiﬁcant
differences in HLADR expression between the two groups of hip frac-
ture patients and healthy controls.
Recovery after hip fracture is a long process and only one-third of
patients have been reported to return to their pre-fracture functional
status one year after the fracture (Magaziner et al., 2000). Previous
ﬁndings have suggested that stress induced immune dysregulation
may persist even after chronic stress has ablated (Kiecolt-Glaser et al.,
1996). This lasting, detrimental effect of stress might reﬂect a prema-
ture ageing of immune system associated with chronic stress (Gouin
et al., 2008). In an attempt to examine the long term effect of depression
on immune suppression we examined the monocyte function on hip
fracture patients with post-fracture depression at six months after
surgery and reported a signiﬁcant suppression in monocyte superoxide
generation in hip fracture patients with depression even 6 months
post-surgery. The effects of stress on monocyte superoxide function in
hip fracture patients are therefore long-lasting.
It should be acknowledged that the present study is not without
limitations. With an observational design, direction of causality cannot
be determined, thus it is possible that the monocyte function changes
and depressive symptoms observed could both result from a confound-
ing variable such as variations in clinical outcomes, e.g., pain, or surgical
complications. Our study did not include self-reported measures of
pain, however, pain medication and other medications that patients
were taking were not associated with either monocyte function or
depressive symptoms. Further, neither were there any associations
with surgery type or anaesthetic type, which might be expected to in-
ﬂuence clinical outcomes. Nonetheless, it should be noted that some
unmeasured third factor such as pain might underlie our observed
associations.
4.1. Conclusions
In this study, we have proposed that the development of depression
in hip fracture patients post-surgery results in immune dysregulation,
due to reduced bactericidal functioning of monocytes. The persistence
of impairment in monocyte functioning in depressed hip fracture
patients six months after the surgery raises the possibility of a long
term and detrimental effect of depression and hip fracture on immune
function. Indeed these data supplement our previous reports of this
patient cohort showing reduced long term physical recovery in those
who developed depressive symptoms (Phillips et al., 2013). Despite
numerous reports of high prevalence of depression in hip fracture
patients, the treatment and prevention of depression in these patients
have received limited attention. Our results suggest that management of
depression in these patients may have an impact on the recovery of
these patients.
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